|
Nov 7
|
Rhythm Pharmaceuticals Inc (RYTM) Reports Q3 2023 Financial Results
|
|
Nov 7
|
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
|
|
Nov 2
|
Rhythm Pharmaceuticals Receives Positive CADTH Reimbursement Recommendation for IMCIVREE® (setmelanotide)
|
|
Sep 8
|
EVP Jennifer Lee Sells 6,166 Shares of Rhythm Pharmaceuticals Inc (RYTM)
|
|
Sep 8
|
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
|
|
Sep 8
|
Rhythm Pharmaceuticals Announces Update to September Conference Participation
|
|
Sep 6
|
Rhythm Pharmaceuticals Announces New ICD-10 Diagnosis Code Established for Bardet-Biedl Syndrome
|
|
Jul 19
|
Rhythm Pharmaceuticals Announces Two Publications Detailing Burden of Hyperphagia and Obesity on Patients and Caregivers Living with Bardet-Biedl Syndrome
|
|
Jul 18
|
Rhythm Pharmaceuticals to Report Second Quarter 2023 Financial Results on Tuesday, August 1, 2023
|
|
May 2
|
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Misses Revenue Estimates
|
|
May 2
|
Rhythm Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Update
|